CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for ImmunoClin Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

ImmunoClin Corp
1420 N St NW Ste 102
Phone: (202) 838-8141p:202 838-8141 WASHINGTON, DC  20005-2876  United States
This company is no longer actively traded on any major stock exchange.
Business Summary
ImmunoClin Corporation is a healthcare company. The Company's products include Multi-Variant Atherosclerosis Risk Assessment (MARA), Genetic Alzheimer's Risk Discovery (GARD), PRIMALEUKIN and DACTELLIGENCE. MARA is an algorithm to analyze the complex multi-variant data (cytokines and cellular markers) to identify people who are at risk of having heart attack. MARA detects inflammatory factors that contribute to causing or enhance processes leading to the obstruction of blood flow and ultimately to cardiovascular event. GARD is a genetic test for multiple genetic polymorphisms (variants) associated with increased risk of the common form of dementia: late-onset Alzheimer's disease. PRIMALEUKIN is an anti-infective therapy, which is known as interleukin-22 (IL-22). DACTELLIGENCE is a disruptive technology to engineer a sensor using a mathematically modeled fractal dactyl surface with repeating patterns, variants, creating topographically confined cages.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
10/31/20141/31/2014YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director Dorothy H.Bray 58 12/13/2013 12/13/2013
Chief Financial Officer, Treasurer James S.Munro 45 12/13/2013 12/13/2013
Chief Operating Officer, General Counsel, Secretary, Director Chad S.Johnson 47 12/13/2013 4/25/2013
Acting Chief Scientific Officer, Director KhadijaBenlhassan 39 3/1/2014 3/1/2014

General Information
Stock Exchange: OTC
Federal Tax Id: 320337695


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023